FDAnews
www.fdanews.com/articles/123954-watson-files-anda-for-loseasonique

Watson Files ANDA for LoSeasonique

January 25, 2010
Watson Pharmaceuticals has filed an ANDA to market a generic version of Teva Pharmaceutical Industries’ LoSeasonique, an oral contraceptive. The company is seeking approval for its contraceptive containing 0.1 mg ethinyl estradiol and 0.02 mg levonorgestrel before LoSeasonique’s U.S. patent expires, Watson said. The patent is owned by Duramed Pharmaceuticals, a subsidiary of Teva.
Generic Line